DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

11297	Companies
251095	Keywords
180062	Articles
136943	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 7 months ago

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
DBV Technologies secures FDA agreement for Viaskin Peanut Patch BLA submission in 4-7-year-olds, accelerating launch timeline by approximately one year. Unaudited 2024 financial results reported

FDA Agreement DBV Technologies Unaudited Financial Results Viaskin Peanut Patch BLA Submission
BRIEF

published on 02/25/2025 at 22:06, 1 year 8 months ago

DBV Technologies au congrès AAAAI/WAO pour présenter des avancées sur l'allergie à l'arachide

Étude Clinique DBV Technologies Allergie À L'arachide Patch VIASKIN® Congrès AAAAI/WAO
BRIEF

published on 02/25/2025 at 22:06, 1 year 8 months ago

DBV Technologies at AAAAI/WAO Congress to Present Advances in Peanut Allergy

Clinical Study DBV Technologies Peanut Allergy AAAAI/WAO Congress VIASKIN® Patch
PRESS RELEASE

published on 02/25/2025 at 22:01, 1 year 8 months ago

DBV Technologies participera au prochain congrès conjoint AAAAI/WAO
DBV Technologies participera au prochain congrès conjoint AAAAI/WAO en présentant les résultats de l'étude sur l'immunothérapie épicutanée avec VIASKIN® peanut pour les enfants allergiques à l'arachide

Immunothérapie DBV Technologies Viaskin Peanut Congrès Conjoint AAAAI/WAO
PRESS RELEASE

published on 02/25/2025 at 22:01, 1 year 8 months ago

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates

DBV Technologies Epicutaneous Immunotherapy Viaskin Peanut Patch AAAAI/WAO Joint Congress PEPITES Study
BRIEF

published on 01/13/2025 at 22:10, 1 year 9 months ago

Bilan de Liquidité Semestriel de DBV Technologies

Contrat De Liquidité ODDO BHF Transactions Boursières DBV Technologies VIASKIN®
BRIEF

published on 01/13/2025 at 22:10, 1 year 9 months ago

DBV Technologies Half-Yearly Liquidity Statement

Liquidity Contract ODDO BHF Stock Market Transactions DBV Technologies VIASKIN®
PRESS RELEASE

published on 01/13/2025 at 22:05, 1 year 9 months ago

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
DBV Technologies publie le bilan semestriel de son contrat de liquidité avec ODDO BHF. Détails des transactions et volumes échangés. Focus sur le patch VIASKIN® pour les allergies alimentaires

Contrat De Liquidité ODDO BHF DBV Technologies Allergies Alimentaires Patch VIASKIN®
PRESS RELEASE

published on 01/13/2025 at 22:05, 1 year 9 months ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
DBV Technologies issues Half-Year Report on liquidity contract with ODDO BHF, revealing assets in the account and transaction details

Liquidity Contract Half-year Report Biopharmaceutical Company ODDO BHF DBV Technologies
BRIEF

published on 12/02/2024 at 22:35, 1 year 11 months ago

DBV Technologies : Droits de vote et actions au 30 novembre 2024

Droits De Vote Capital Social Actions DBV Technologies NYSE Euronext Paris

Accesswire

Published on 11/09/2026 at 15:00, 2 minutes ago

Shelfietech Launched New Retail Software Platform
Published on 11/09/2026 at 14:30, 32 minutes ago

Boron One Applies for New Exploration Licence
Published on 11/09/2026 at 14:15, 47 minutes ago

Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
Published on 11/09/2026 at 14:00, 1 hour 2 minutes ago

Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
Published on 11/09/2026 at 13:35, 1 hour 27 minutes ago

Gabriel Provides Corporate Update

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 14:55, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/09/2026 at 14:54, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/09/2026 at 14:54, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 11/09/2026 at 14:53, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 11/09/2026 at 14:52, 9 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Rotork plc

Les Echos

Published on 11/09/2026 at 14:31, 31 minutes ago

261109 BENETEAU Transactions sur actions propres
Published on 11/09/2026 at 10:32, 4 hours 30 minutes ago

Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 4 hours 30 minutes ago

Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 8 hours 2 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 8 hours 2 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA

View all LES ECHOS COMFI WIRE